1. Circulating IL-1β, IL-17, and IP-10 as Potential Predictors of Hepatitis B Virus Infection Prognosis
   Zhenzhen Su et al, 2022, Journal of Immunology Research CrossRef
2. The Relationship Between Serum IL-17 Level and Viral Load in Chronic Hepatitis B
   Maliheh Metanat et al, 2019, Archives of Clinical Infectious Diseases CrossRef
3. Boosting Akt Pathway by Rupatadine Modulates Th17/Tregs Balance for Attenuation of Isoproterenol-Induced Heart Failure in Rats
   Lamiaa A. Ahmed et al, 2021, Frontiers in Pharmacology CrossRef
4. Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression
   Arshi Khanam et al, 2021, International Journal of Molecular Sciences CrossRef
5. Gamma Delta T Cells and Their Involvement in COVID-19 Virus Infections
   Georg von Massow et al, 2021, Frontiers in Immunology CrossRef
6. Retinoic Acid: A New Old Friend of IL-17A in the Immune Pathogeny of Liver Fibrosis
   Daria M. Kartasheva-Ebertz et al, 2021, Frontiers in Immunology CrossRef
7. Immunity and Fibrogenesis: The Role of Th17/IL-17 Axis in HBV and HCV-induced Chronic Hepatitis and Progression to Cirrhosis
   Feliciano Chanana Paquissi, 2017, Frontiers in Immunology CrossRef
8. Interleukin 1 (IL-1)- and IL-23-Mediated Expansion of Filarial Antigen-Specific Th17 and Th22 Cells in Filarial Lymphedema
   R. Anuradha et al, 2014, Clinical and Vaccine Immunology CrossRef
9. T Helper 17/Regulatory T Cell Balance and Experimental Models of Peritoneal Dialysis-Induced Damage
   Georgios Liappas et al, 2015, BioMed Research International CrossRef
10. Bone marrow-derived monocyte infusion improves hepatic fibrosis by decreasing osteopontin, TGF-β1, IL-13 and oxidative stress
    Veruska Cintia Alexandrino de Souza et al, 2017, World Journal of Gastroenterology CrossRef
11. Promising Therapy Candidates for Liver Fibrosis
    Ping Wang et al, 2016, Frontiers in Physiology CrossRef
12. Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets
    Feliciano Chanana Paquissi, 2016, Frontiers in Immunology CrossRef
13. The Molecular Mechanism of Transforming Growth Factor-β Signaling for Intestinal Fibrosis: A Mini-Review
    Sun-Mi Yun et al, 2019, Frontiers in Pharmacology CrossRef
14. Indoleamine 2,3-dioxygenase 1 deficiency attenuates CCl4-induced fibrosis through Th17 cells down-regulation and tryptophan 2,3-dioxygenase compensation
    Weichao Zhong et al, 2017, Oncotarget CrossRef